Suppr超能文献

内镜套扎结扎术可降低马洛里-韦斯综合征的再出血率,优于使用止血夹加肾上腺素进行止血。

Endoscopic band ligation could decrease recurrent bleeding in Mallory-Weiss syndrome as compared to haemostasis by hemoclips plus epinephrine.

机构信息

Gastroenterology Department, Digestive Endoscopy Unit, Rouen University Hospital, Rouen Cedex, France.

出版信息

Aliment Pharmacol Ther. 2009 Aug 15;30(4):399-405. doi: 10.1111/j.1365-2036.2009.04051.x. Epub 2009 May 26.

Abstract

BACKGROUND

Mallory-Weiss syndrome (MWS) with active bleeding at endoscopy may require endoscopic haemostasis the modalities of which are not well-defined.

AIM

To compare the efficacy of endoscopic band ligation vs. hemoclip plus epinephrine (adrenaline) in bleeding MWS.

METHODS

From 2001 to 2008, 218 consecutive patients with a MWS at endoscopy were hospitalized in our Gastrointestinal Bleeding Unit. In 56 patients (26%), an endoscopic haemostasis was required because of active bleeding. Band ligation was performed in 29 patients (Banding group), while hemoclip application plus epinephrine injection was performed in 27 patients (H&E group). Treatment efficacy and early recurrent bleeding were retrospectively compared between the two groups.

RESULTS

Primary endoscopic haemostasis was achieved in all patients. Recurrent bleeding occurred in 0% in Banding group vs. 18% in H&E group (P = 0.02). The use of hemoclips plus epinephrine (OR = 3; 95% CI = 1.15-15.8) and active bleeding at endoscopy (OR = 1.9; 95% CI = 1.04-5.2) were independent predictive factors of early recurrent bleeding.

CONCLUSIONS

Haemostasis by hemoclips plus epinephrine was an independent predictive factor of rebleeding. This result suggests that band ligation could be the first choice endoscopic treatment for bleeding MWS, but requires further prospective assessment.

摘要

背景

Mallory-Weiss 综合征(MWS)伴内镜下活动性出血可能需要内镜止血,但止血方式尚未明确。

目的

比较内镜套扎与夹闭联合肾上腺素在 MWS 出血中的疗效。

方法

2001 年至 2008 年,218 例 MWS 患者在我院胃肠出血科住院。56 例(26%)患者因活动性出血需要内镜止血。29 例患者接受套扎治疗(套扎组),27 例患者接受夹闭联合肾上腺素注射治疗(H&E 组)。回顾性比较两组治疗效果和早期再出血情况。

结果

所有患者均达到初次内镜止血。套扎组无再出血(0%),H&E 组再出血率为 18%(P=0.02)。夹闭联合肾上腺素应用(OR=3;95%CI=1.15-15.8)和内镜下活动性出血(OR=1.9;95%CI=1.04-5.2)是早期再出血的独立预测因素。

结论

夹闭联合肾上腺素是再出血的独立预测因素。这一结果表明,套扎可能是治疗 MWS 出血的首选内镜治疗方法,但需要进一步前瞻性评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验